HCWB

← Markets

HCWBHCW Biologics Inc.

Discussion

Nothing said here yet.

to join the conversation.

—

Tue, Aug 25
8:00 AMstocktitan.netHCW Biologics’ TGF-β Trap and IL-15 Fusion is a Novel Moiety to Enhance Immunotherapeutic Activity against Diseased Cells
Fri, Aug 14
2:15 PMYahooHCW Biologics Reports Second Quarter 2026 Business and Clinical Development Highlights and Financial Results
Wed, Jul 29
8:06 AMYahooHCW Biologics Inc. Announces Pricing of $1.6 Million Private Placement Offering
Thu, Jul 23
7:00 AMYahooHCW Biologics Reaches Milestones for Its Proprietary Tetravalent Second-Generation T-Cell Engager Program On Track To Initiate Clinical Trials in First Half 2027
Tue, Jun 30
7:25 AMYahooHCW Biologics Regained Compliance with Bid Price Rule Per Nasdaq Compliance Letter
Fri, Jun 26
7:55 AMYahooHCW Biologics Announces 1-for-6 Reverse Stock Split Effective on June 30, 2026
Tue, Jun 16
6:00 AMYahooHCW Biologics Announces Positive Results for Preliminary Human Data Readout for Phase 1 Clinical Trial Evaluating IL-2 Based Fusion Immunotherapeutic, HCW9302 Monotherapy, in Alopecia Areata
Wed, May 27
6:45 AMYahooHCW Biologics Exercised Option to Regain Full Rights for Two Commercial-Ready Reagents from Wugen
Fri, May 22
3:02 PMYahooE.F. Hutton & Co. Serves as Sole Placement Agent on HCW Biologics Inc. $4.0 Million Private Placement
Thu, May 21
8:53 AMYahooHCW Biologics Inc. Announces Pricing of Approximately $4.0 Million Private Placement Offering At-the-Market Under Nasdaq Rules
Thu, May 14
3:25 PMYahooHCW Biologics Reports First Quarter 2026 Business Highlights and Financial Results
6:30 AMYahooHCW Biologics Discovers that HCW11-040 Prevents Bronchopulmonary Dysplasia (BPD) During IND-Enabling Studies